Your browser doesn't support javascript.
loading
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Rugo, Hope S; Pennella, Eduardo J; Gopalakrishnan, Unmesh; Hernandez-Bronchud, Miguel; Herson, Jay; Koch, Hans Friedrich; Loganathan, Subramanian; Deodhar, Sarika; Marwah, Ashwani; Manikhas, Alexey; Bondarenko, Igor; Mukhametshina, Guzel; Nemsadze, Gia; Parra, Joseph D; Abesamis-Tiambeng, Maria Luisa T; Baramidze, Kakhaber; Akewanlop, Charuwan; Vynnychenko, Ihor; Sriuranpong, Virote; Mamillapalli, Gopichand; Roy, Sirshendu; Yanez Ruiz, Eduardo Patricio; Barve, Abhijit; Fuentes-Alburo, Adolfo; Waller, Cornelius F.
Affiliation
  • Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Hope.Rugo@ucsf.edu.
  • Pennella EJ; Viatris Inc, Canonsburg, PA, USA.
  • Gopalakrishnan U; MaxCyte, Inc, Gaithersburg, MD, USA.
  • Hernandez-Bronchud M; Viatris Inc, Bangalore, India.
  • Herson J; GénesisCare Corachan, Barcelona, Spain.
  • Koch HF; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Loganathan S; Viatris Inc, Hannover, Germany.
  • Deodhar S; Biocon Research Limited, Bangalore, India.
  • Marwah A; Biocon Research Limited, Bangalore, India.
  • Manikhas A; Biocon Research Limited, Bangalore, India.
  • Bondarenko I; City Clinical Oncology Dispensary, Saint Petersburg, Russia.
  • Mukhametshina G; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine.
  • Nemsadze G; Regional Clinical Oncological Center, Kazan, Russia.
  • Parra JD; Institute of Clinical Oncology, Tbilisi, Georgia.
  • Abesamis-Tiambeng MLT; St Luke's Medical Center, Quezon City, Philippines.
  • Baramidze K; Cardinal Santos Medical Center, Manila, Philippines.
  • Akewanlop C; Golden Fleece 21 Century Health House Ltd, Tbilisi, Georgia.
  • Vynnychenko I; Siriraj Hospital, Bangkok, Thailand.
  • Sriuranpong V; Sumy State University, Sumy, Ukraine.
  • Mamillapalli G; King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
  • Roy S; City Cancer Center, Vijayawada, India.
  • Yanez Ruiz EP; Curie Manavata Cancer Centre, Nasik, India.
  • Barve A; Universidad de la Frontera, Temuco, Chile.
  • Fuentes-Alburo A; Viatris Inc, Canonsburg, PA, USA.
  • Waller CF; Viatris Inc, Canonsburg, PA, USA.
Breast Cancer Res Treat ; 188(2): 369-377, 2021 Jul.
Article in En | MEDLINE | ID: mdl-34125340
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2021 Document type: Article Affiliation country: United States Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2021 Document type: Article Affiliation country: United States Country of publication: Netherlands